Standard & Poor’s Ratings Services announced that it has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
S&P then said that it had withdrawn the ratings at the company’s request.
“The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization,” said S&P.
“These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided,” the announcement concluded.
Was this article valuable?
Here are more articles you may enjoy.
Insurer Interest in AI Exclusions Growing as Risk Becomes Omnipresent 
Florida Appeals Court Strikes Jury’s $335,000 Award in Universal Plumbing Claim 
NYC Says Source of Legionnaires’ Disease Has Been Eliminated 
London Broker Howden Plots Giant Capital Raise on IPO Path 
